Catalent Gross Profit

Catalent (CTLT) currently reports a gross profit of $970M as of September 2024. That compares with $980M in the prior-year period — down 1.8% year over year. That is below the Healthcare sector average of $67B. Use the charts on this page to explore Catalent's gross profit history and peer comparisons.

Catalent's gross profit decreased from $980M to $970M — a 1.8% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Catalent's gross profit of $970M is lower than the Healthcare sector average of $67B. That is roughly 98.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Catalent reported $970M in gross profit as of September 2024. That compares with $980M in the prior-year period — down 1.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $970M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $67B. From there, open related valuation or income-statement pages for Catalent, and consider following CTLT for alerts when major investors trade the stock.